Exom is proud to announce to being awarded the GHP Global Excellence Award by Global Health & Pharma as “Most Innovative Full-Service CRO – 2022” for our pioneering and cutting-edge use of technology (with our Genius SUITE™) in clinical trials to support study stakeholders.
“Exom’s innovative approach to using advanced technological solutions in clinical trials brings us this prestigious award for the third time. The award as ‘Most Innovative Full-Service CRO’ means recognition that our mission, launched in 2014, has not only been right, but is also validated by dozens of smarter clinical studies, conducted with higher data quality standards, performance and efficiency “, Luigi Visani MD, CEO & Founder of Exom Group, said.
Patrick McManus, Chief Development Officer of Exom Group, added, “It is precisely this vision that we want to drive forward together with Clinscience and to support the pharmaceutical and biotech industry in bringing drugs to market faster for millions of patients.”
